U.S. Semi-solid Dosage Cdmo Market Size & Outlook
Related Markets
U.S. semi-solid dosage cdmo market highlights
- The U.S. semi-solid dosage cdmo market generated a revenue of USD 12,876.4 million in 2024 and is expected to reach USD 26,069.8 million by 2030.
- The U.S. market is expected to grow at a CAGR of 12.5% from 2025 to 2030.
- In terms of segment, topical was the largest revenue generating route of administration in 2024.
- Transdermal is the most lucrative route of administration segment registering the fastest growth during the forecast period.
Semi-solid dosage cdmo market data book summary
| Market revenue in 2024 | USD 12,876.4 million |
| Market revenue in 2030 | USD 26,069.8 million |
| Growth rate | 12.5% (CAGR from 2025 to 2030) |
| Largest segment | Topical |
| Fastest growing segment | Transdermal |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Topical, Transdermal |
| Key market players worldwide | The Lubrizol Corp, Cambrex, Contract Pharmaceuticals Limited, Bora Pharmaceuticals, Ascendia Pharmaceuticals, Pierre Fabre, Piramal Pharma Solutions, DPT Laboratories, LGM Pharma, Pace Analytical Services |
Other key industry trends
- In terms of revenue, U.S. accounted for 37.3% of the global semi-solid dosage cdmo market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. semi-solid dosage cdmo market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 26,069.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Semi-Solid Dosage CDMO Market Scope
Semi-Solid Dosage CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| LGM Pharma | View profile | 101-250 | Nashville, Tennessee, United States, North America | https://lgmpharma.com/ |
| DPT Laboratories | View profile | 1001-5000 | San Antonio, Texas, United States, North America | https://www.dptlabs.com |
| Ascendia Pharmaceuticals | View profile | 101-250 | North Brunswick, New Jersey, United States, North America | https://ascendiapharma.com/ |
| Bora Pharmaceuticals | View profile | 501-1000 | Taipei, T'ai-pei, Taiwan, Asia | http://www.bora-corp.com/ |
| Contract Pharmaceuticals Limited | View profile | 251-500 | Mississauga, Ontario, Canada, North America | http://www.cplltd.com |
| Pierre Fabre | View profile | 10001+ | Castres-gironde, Aquitaine, France, Europe | http://www.pierre-fabre.com |
| Cambrex | View profile | 1001-5000 | East Rutherford, New Jersey, United States, North America | http://www.cambrex.com |
| Pace Analytical Services | View profile | 11-50 | Woburn, Massachusetts, United States, North America | https://www.pacelifesciences.com |
| Piramal Pharma Solutions | View profile | 1001-5000 | Riverview, Michigan, United States, North America | http://www.piramalpharmasolutions.com/ |
| The Lubrizol Corp | View profile | 5001-10000 | Wickliffe, Ohio, United States, North America | http://www.lubrizol.com/ |
U.S. semi-solid dosage cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to semi-solid dosage cdmo market will help companies and investors design strategic landscapes.
Topical was the largest segment with a revenue share of 99.58% in 2024. Horizon Databook has segmented the U.S. semi-solid dosage cdmo market based on topical, transdermal covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to U.S. semi-solid dosage cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. semi-solid dosage cdmo market databook
-
Our clientele includes a mix of semi-solid dosage cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. semi-solid dosage cdmo market , including forecasts for subscribers. This country databook contains high-level insights into U.S. semi-solid dosage cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. semi-solid dosage cdmo market size, by route of administration, 2018-2030 (US$M)
U.S. Semi-Solid Dosage CDMO Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
